PCCTC Trial Establishes Safety, Antitumor Activity of Apalutamide
July 25, 2017 | Press Releases
Study represents a new standard that demonstrates the patient experience, useful for physicians when considering options to continue treatment until the patient is no longer clinically benefiting.
Committed to world-class science!
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.